Medicine quality in high-income countries: The obstacles to comparative prevalence studies
{{output}}
The entry of falsified and substandard medicines into the legitimate pharmaceutical supply chain has negative impacts on healthcare systems, patient safety, and patient access to medicine. The COVID-19 pandemic has highlighted the importance of access to safe ... ...
